Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9001-9050 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05416996
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
N/AActive, not recruiting
88 participants
Started: Jun 5, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06386042
Guideline Implementation and Quality of Care in Patients With Heart Failure: the TITRATE-HF Registry
N/AActive, not recruiting
4,289 participants
Started: Jun 5, 2022 · Completed: Apr 30, 2029
1 condition2 sponsors1 location
NCT05244213
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC
PHASE2Active, not recruiting
35 participants
Started: Jun 4, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05408936
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
N/AActive, not recruiting
80 participants
Started: Jun 3, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05412212
Brief Educational Video for Patients Prescribed LTBI Treatment
NAActive, not recruiting
1,898 participants
Started: Jun 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05056896
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
EARLY_PHASE1Active, not recruiting
161 participants
Started: Jun 3, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05092958
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
PHASE3Active, not recruiting
654 participants
Started: Jun 3, 2022 · Completed: Dec 10, 2025
18 conditions1 sponsor276 locations
NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
PHASE2Active, not recruiting
130 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2028
2 conditions3 sponsors25 locations
NCT05243862
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
PHASE2Active, not recruiting
18 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition3 sponsors3 locations
NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
63 participants
Started: Jun 2, 2022 · Completed: Sep 5, 2026
1 condition1 sponsor34 locations
NCT05282485
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
NAActive, not recruiting
140 participants
Started: Jun 2, 2022 · Completed: Sep 10, 2027
3 conditions5 sponsors1 location
NCT05417906
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
PHASE2Active, not recruiting
110 participants
Started: Jun 2, 2022 · Completed: Sep 30, 2026
2 conditions2 sponsors2 locations
NCT06158789
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NAActive, not recruiting
6 participants
Started: Jun 2, 2022 · Completed: Jan 19, 2024
1 condition2 sponsors1 location
NCT03856515
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
NAActive, not recruiting
169 participants
Started: Jun 2, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05409261
Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
PHASE2Active, not recruiting
200 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2025
4 conditions6 sponsors1 location
NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
PHASE2/PHASE3Active, not recruiting
259 participants
Started: Jun 2, 2022 · Completed: Feb 27, 2029
1 condition1 sponsor35 locations
NCT05428969
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
PHASE1/PHASE2Active, not recruiting
181 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
4 conditions1 sponsor10 locations
NCT05991167
"EndeavorRx® Prospective Product Registry (Expedition EndeavorRx)"
N/AActive, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06177210
Type 2 Diabetes Remission
N/AActive, not recruiting
20 participants
Started: Jun 1, 2022 · Completed: Aug 30, 2025
1 condition2 sponsors1 location
NCT04808206
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
N/AActive, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor3 locations
NCT05062915
Diagnostic Work up and Management of Acute Onset Vertigo
NAActive, not recruiting
90 participants
Started: Jun 1, 2022 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT06633094
Home Management of Pediatric Buckle Fractures
NAActive, not recruiting
46 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT03935997
Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program
NAActive, not recruiting
594 participants
Started: Jun 1, 2022 · Completed: Jan 31, 2026
1 condition7 sponsors4 locations
NCT06499337
Safety Plan in Emergency Department to Prevent Suicidal Attempt Recidive
N/AActive, not recruiting
80 participants
Started: Jun 1, 2022 · Completed: Jul 31, 2024
4 conditions1 sponsor1 location
NCT06240169
Effect of Age on the Success of DPC Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis
NAActive, not recruiting
174 participants
Started: Jun 1, 2022 · Completed: Mar 30, 2024
1 condition1 sponsor1 location
NCT06647719
Postoperative Care After Carpal Tunnel Release Using Short Educational Videos
NAActive, not recruiting
84 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05795400
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NAActive, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT04739995
Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia
PHASE4Active, not recruiting
99 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05366712
Nexus Evaluation Primary Trident II Uncemented Shell
NAActive, not recruiting
125 participants
Started: Jun 1, 2022 · Completed: Nov 25, 2034
4 conditions2 sponsors1 location
NCT05220631
Digital Nutrition Intervention for Older Adults
NAActive, not recruiting
369 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
3 conditions5 sponsors1 location
NCT05448092
Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt
N/AActive, not recruiting
500 participants
Started: Jun 1, 2022 · Completed: Jun 26, 2025
3 conditions19 sponsors8 locations
NCT06283017
Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
NAActive, not recruiting
14 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2024
4 conditions2 sponsors1 location
NCT05375903
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE1Active, not recruiting
51 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor13 locations
NCT05564247
Wheelchair Skills Training for Children and Youth
NAActive, not recruiting
60 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor3 locations
NCT06457698
Temporomandibular Bioviscosuplementation (Platelet-Rich Plasma Combined With Hyaluronic Acid) After Double-Puncture Arthrocentesis: a Randomized Controlled Trial
NAActive, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06091137
Appendectomy and Colorectal Cancer
N/AActive, not recruiting
180,000 participants
Started: Jun 1, 2022 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05558436
Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer
N/AActive, not recruiting
662 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05368350
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
NAActive, not recruiting
12 participants
Started: Jun 1, 2022 · Completed: Apr 16, 2026
2 conditions1 sponsor1 location
NCT05248477
Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)
NAActive, not recruiting
2,377 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05318573
A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
PHASE2Active, not recruiting
120 participants
Started: Jun 1, 2022 · Completed: Nov 30, 2029
2 conditions2 sponsors23 locations
NCT05385692
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors
PHASE1Active, not recruiting
22 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT06670989
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
NAActive, not recruiting
30 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05818449
Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)
NAActive, not recruiting
850 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2025
1 condition16 sponsors41 locations
NCT07127497
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
PHASE2Active, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Oct 1, 2028
1 condition1 sponsor1 location
NCT05365776
Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion
NAActive, not recruiting
220 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors7 locations
NCT05365711
Carriage of Beta Haemolytic Streptococci During Pregnancy
N/AActive, not recruiting
1,040 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05323721
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
PHASE4Active, not recruiting
6,805 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2023
1 condition1 sponsor1 location
NCT05329025
A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
PHASE2Active, not recruiting
100 participants
Started: Jun 1, 2022 · Completed: Jan 1, 2024
1 condition1 sponsor1 location
NCT05394675
A Study of DS-9606a in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
88 participants
Started: May 31, 2022 · Completed: Feb 19, 2026
4 conditions1 sponsor7 locations
NCT05355298
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
62 participants
Started: May 31, 2022 · Completed: May 1, 2026
3 conditions1 sponsor13 locations